Engler, J. ., Filliter, C. ., Montastruc, F. ., Abenhaim, H. ., Rej, S. ., & Renoux, C. . (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. J Affect Disord, 350, 813–821. http://doi.org/10.1016/j.jad.2024.01.163
Antidepressants
Jeffery, A. ., Bhanu, C. ., Walters, K. ., Wong, I. C., Osborn, D. ., & Hayes, J. F. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295
Taqi, A. ., Gran, S. ., & Knaggs, R. D. (2023). Analgesic utilization in people with knee osteoarthritis: A population-based study using primary care data. Pain Pract. http://doi.org/10.1111/papr.13212
Jeffery, A. ., Bhanu, C. ., Walters, K. ., Wong, I. C. K., Osborn, D. ., & Hayes, J. F. (2022). Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. Br J Psychiatry, 1–7. http://doi.org/10.1192/bjp.2022.160
Cao, T. X. D., Filliter, C. ., Montastruc, F. ., H. Y. Yu, O. ., Fergusson, E. ., Rej, S. ., … Renoux, C. . (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231–237. http://doi.org/10.1016/j.jad.2022.08.094
Jayasooriya, N. ., Blackwell, J. ., Saxena, S. ., Bottle, A. ., Petersen, I. ., Creese, H. ., … Pollok, R. C. G. (2022). Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population-based study. Aliment Pharmacol Ther. http://doi.org/10.1111/apt.16820
Joseph, R. M., Jack, R. H., Morriss, R. ., Knaggs, R. D., Butler, D. ., Hollis, C. ., … Coupland, C. . (2022). The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records. BMC Med, 20, 43. http://doi.org/10.1186/s12916-022-02247-x